FAIMS technology holds potential to be effective screening tool for pancreatic cancer
 

In research published in the latest edition of the UEG Journal, Scientists in Finland demonstrated that there is variance in the volatile compounds found in the urine of pancreatic cancer patients to that of healthy controls.

More...